Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00589654 · ClinicalTrials.gov registry record

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

A clinical trial of Breast Cancer and Amenorrhea, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
810
Enrollment target
1
Study location

NCT00589654: Active study of Breast Cancer and Amenorrhea, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00589654 is a study of Breast Cancer and Amenorrhea that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 810 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00589654, a study of Breast Cancer and Amenorrhea, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
810 participants
Enrollment target
1
Study location

Study Summary

Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a cohort of youg breast cancer patients.

Interventions

  • OTHER Questionnaire

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 810 participants
Start Date 1997-12
Est. Completion 2026-12
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT00589654 still lists

NCT00589654 is an observational study that tracks outcomes without assigning an intervention. The registered 810 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower).

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.

NCT00589654 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00589654 about?

NCT00589654 is a clinical study titled "Menstrual Cycle Maintenance and Quality of Life: A Prospective Study". Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a c...

What is the current status of trial NCT00589654?

This trial is currently active not recruiting. The enrollment target is 810 participants. The study started on 1997-12. Estimated completion is 2026-12.

What conditions does trial NCT00589654 study?

This clinical trial studies the following conditions: Breast Cancer, Amenorrhea, Menstrual Cycle.

What interventions are being tested in trial NCT00589654?

The interventions under investigation include: Questionnaire (OTHER).

Who is sponsoring clinical trial NCT00589654?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00589654 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00589654's enrollment target sits among peer trials

810 141st of 1224 higher than 1,083 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05519085 · 810 participants · Phase 3

    A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  • NCT06529094 · 808 participants · NA

    Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

  • NCT04613596 · 806 participants · Phase 2

    Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • NCT06065098 · 806 participants · NA

    Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00589654, the US trial registry maintained by the National Library of Medicine. NCT00589654 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.